Abstract
C15H12O5, monoclinic, P21/c (no. 14), a = 16.1399(4) Å, b = 19.2950(5) Å, c = 8.2567(2) Å, β = 97.078(1)°, V = 2551.70(11) Å3, Z = 8, R gt (F) = 0.0440, wRref (F 2) = 0.1326, T = 299.15 K.
A part of the molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Data collection and handling.
| Crystal: | Colourless needle |
| Size: | 0.20 × 0.18 × 0.15 mm |
| Wavelength: μ: |
Mo Kα radiation (0.71073 Å) 0.11 mm−1 |
| Diffractometer, scan mode: θ max, completeness: |
XtaLAB AFC12 (RINC), 28.3°, >99 % |
| N(hkl)measured, N(hkl)unique, R int: | 62952, 6299, 0.077 |
| Criterion for I obs, N(hkl)gt: | I obs > 2 σ(I obs), 4393 |
| N(param)refined: | 373 |
| Programs: | Bruker, 1 Olex2, 2 SHELX, 3 Diamond 4 |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
| Atom | x | y | z | U iso*/U eq |
|---|---|---|---|---|
| O1 | 0.13444 (7) | 0.03007 (6) | 0.24866 (16) | 0.0640 (3) |
| O2 | 0.21994 (7) | −0.05553 (6) | 0.33994 (17) | 0.0675 (3) |
| H2 | 0.176708 | −0.072383 | 0.365318 | 0.101* |
| O3 | 0.48132 (7) | 0.19619 (5) | −0.00492 (16) | 0.0606 (3) |
| O4 | 0.40405 (7) | 0.31753 (6) | −0.00362 (19) | 0.0715 (4) |
| H4 | 0.371890 | 0.345503 | 0.029831 | 0.107* |
| O5 | 0.49253 (8) | 0.40326 (6) | 0.06636 (17) | 0.0688 (3) |
| C1 | 0.20332 (9) | 0.00508 (8) | 0.26788 (18) | 0.0475 (3) |
| C2 | 0.27806 (9) | 0.03739 (7) | 0.21094 (17) | 0.0435 (3) |
| C3 | 0.35631 (9) | 0.00677 (8) | 0.23988 (19) | 0.0494 (3) |
| H3 | 0.363442 | −0.033834 | 0.300678 | 0.059* |
| C4 | 0.42334 (9) | 0.03664 (7) | 0.1784 (2) | 0.0505 (4) |
| H4A | 0.475625 | 0.015944 | 0.198869 | 0.061* |
| C5 | 0.41451 (9) | 0.09669 (7) | 0.08703 (18) | 0.0447 (3) |
| C6 | 0.33671 (9) | 0.12837 (8) | 0.06145 (19) | 0.0506 (4) |
| H6A | 0.330121 | 0.169647 | 0.003114 | 0.061* |
| C7 | 0.26915 (9) | 0.09869 (8) | 0.12245 (19) | 0.0489 (3) |
| H7 | 0.217140 | 0.119982 | 0.104094 | 0.059* |
| C8 | 0.48834 (10) | 0.12376 (8) | 0.0135 (2) | 0.0511 (4) |
| H8A | 0.5412 (12) | 0.1122 (10) | 0.086 (2) | 0.072 (5)* |
| H8B | 0.4913 (12) | 0.1022 (10) | −0.099 (2) | 0.075 (5)* |
| C9 | 0.54668 (9) | 0.23079 (7) | −0.05642 (18) | 0.0457 (3) |
| C10 | 0.61349 (10) | 0.19746 (8) | −0.11460 (19) | 0.0530 (4) |
| H10 | 0.613420 | 0.149445 | −0.124354 | 0.064* |
| C11 | 0.67974 (10) | 0.23527 (9) | −0.1578 (2) | 0.0590 (4) |
| H11 | 0.723740 | 0.212634 | −0.198263 | 0.071* |
| C12 | 0.68138 (10) | 0.30619 (9) | −0.1417 (2) | 0.0633 (4) |
| H12 | 0.727019 | 0.331355 | −0.168003 | 0.076* |
| C13 | 0.61487 (10) | 0.33976 (8) | −0.0863 (2) | 0.0553 (4) |
| H13 | 0.616050 | 0.387751 | −0.075967 | 0.066* |
| C14 | 0.54609 (9) | 0.30325 (7) | −0.04565 (17) | 0.0450 (3) |
| C15 | 0.47616 (9) | 0.34273 (7) | 0.01016 (19) | 0.0477 (3) |
| O6 | 0.37366 (7) | 0.47515 (6) | 0.17952 (16) | 0.0602 (3) |
| H6 | 0.404622 | 0.449041 | 0.136667 | 0.090* |
| O7 | 0.28228 (7) | 0.39205 (6) | 0.09876 (16) | 0.0668 (3) |
| O8 | 0.05612 (6) | 0.66799 (5) | 0.45496 (14) | 0.0519 (3) |
| O9 | 0.13388 (8) | 0.77558 (6) | 0.36813 (17) | 0.0695 (4) |
| H9 | 0.123099 | 0.734608 | 0.381641 | 0.104* |
| O10 | 0.08518 (9) | 0.87704 (6) | 0.42411 (19) | 0.0811 (4) |
| C16 | 0.30109 (9) | 0.44970 (8) | 0.16670 (18) | 0.0471 (3) |
| C17 | 0.23496 (9) | 0.48914 (7) | 0.23577 (17) | 0.0427 (3) |
| C18 | 0.25562 (9) | 0.54383 (7) | 0.34110 (19) | 0.0474 (3) |
| H18 | 0.311155 | 0.557011 | 0.365936 | 0.057* |
| C19 | 0.19402 (9) | 0.57895 (8) | 0.40954 (19) | 0.0491 (3) |
| H19 | 0.208411 | 0.615310 | 0.481460 | 0.059* |
| C20 | 0.11092 (9) | 0.56045 (7) | 0.37193 (18) | 0.0439 (3) |
| C21 | 0.09008 (9) | 0.50709 (8) | 0.2630 (2) | 0.0507 (4) |
| H21 | 0.034324 | 0.495416 | 0.233880 | 0.061* |
| C22 | 0.15208 (9) | 0.47093 (8) | 0.1970 (2) | 0.0509 (4) |
| H22 | 0.137828 | 0.434179 | 0.126107 | 0.061* |
| C23 | 0.04364 (9) | 0.59434 (7) | 0.4545 (2) | 0.0496 (4) |
| H23A | −0.010727 | 0.583105 | 0.396816 | 0.059* |
| H23B | 0.045760 | 0.577504 | 0.565664 | 0.059* |
| C24 | −0.00196 (8) | 0.70938 (7) | 0.51506 (17) | 0.0425 (3) |
| C25 | −0.06977 (9) | 0.68312 (8) | 0.58304 (19) | 0.0499 (3) |
| H25 | −0.076993 | 0.635472 | 0.590875 | 0.060* |
| C26 | −0.12652 (10) | 0.72791 (9) | 0.6390 (2) | 0.0562 (4) |
| H26 | −0.172226 | 0.710154 | 0.683734 | 0.067* |
| C27 | −0.11623 (11) | 0.79877 (9) | 0.6295 (2) | 0.0598 (4) |
| H27 | −0.155055 | 0.828708 | 0.666215 | 0.072* |
| C28 | −0.04808 (10) | 0.82451 (8) | 0.56523 (19) | 0.0534 (4) |
| H28 | −0.040503 | 0.872235 | 0.561449 | 0.064* |
| C29 | 0.00982 (9) | 0.78126 (7) | 0.50573 (17) | 0.0444 (3) |
| C30 | 0.07875 (10) | 0.81482 (8) | 0.4315 (2) | 0.0532 (4) |
1 Source of materials
0.2722 g 2-(2′–Carboxybenzyl)benzoic acid (1.0 mmol), 0.080 g NaOH (2.0 mmol), and 0.3110 g calcium perchlorate tetrahydrate (1.0 mmol) solids were dissolved into the 16 ml ethanol-water solution (v:v = 1:1) with stirring. The above mixture was stirred at 75 °C for 6 h and cooled to room temperature. It was then filtered and the filtrate was left still for 30 days. The clear light colourless crystals were received.
2 Experimental details
The hydrogen atoms were positioned geometrically (C–H = 0.93–0.97 Å, O–H = 0.82 Å). Their U iso values were set to 1.2 U eq or 1.5 U eq of the parent atoms.
3 Comment
Carboxylate compounds and their metal complexes have exhibited novel structure 5 , 6 and excellent performance in many ways such as vitro antitumor activity, 7 , 8 electrochemical property, 9 antileishmanial, DNA binding, antioxidant, cytotoxicity, antifungal and antibacterial property, 10 and catalysis. 11 Our research group has also synthesized some carboxylic acid metal complexes, which also showed excellent properties in antitumor, catalysis, fluorescence and other aspects. 12 , 13 , 14 , 15 To further investigate the structure and properties of carboxylate metal complexes, in this work, we prepared to synthesize a calcium complex using 2-(2′-carboxybenzyl)benzoic acid, NaOH and calcium perchlorate tetrahydrate. Unfortunately, calcium ions do not take part in coordination, only obtaining the single crystal of 2-(2′-carboxybenzyl)benzoic acid. The molecular structure of the title compound is shown in Figure. The title compound crystallizes in a monoclinic with space group P121/c1 (no. 14). The molecules are linked together by pairs of intermolecular hydrogen bonds (O6–H6· · ·O5 and O4–H4· · ·O7) to form the dimers. In the title compound, the bond lengths of C1–O1 and C30–O10 are 1.2043(18) and 1.2071(19) Å, respectively, which are in agreement with the value of C=O (1.233 Å). However, the bond lengths of C15–O4, C15–O5, C16–O6 and C16–O7 are 1.2534(18), 1.2723(18), 1.2624(17) and 1.2659(18) Å, respectively, which may be due to the double hydrogen bonds in the dimer. The dihedral angles of ring 1 (C2–C3–C4–C5–C6–C7–C2) and ring 2 (C9–C10–C11–C12–C13–C14–C9), ring 3 (C17–C18–C19–C20–C21–C22–C17) and ring 4 (C24–C25–C26–C27–C28–C29–C24) are 38.43 and 46.01°, showing that two 2-(2′-carboxybenzyl)benzoic acid molecules in dimer are not coplanar. The dimers form a one-dimensional zigzag chain-like structure through single O–H· · ·O hydrogen bond.
Acknowledgments
This project was supported by the talent training support of Henan Academy of Sciences (220608035, 231508001, 242208025) and the National Natural Science Foundation of China (No. 21171132, https://doi.org/10.13039/501100001809).
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: talent training support of Henan Academy of Sciences (220608035, 231508001, 242208025) and the National Natural Science Foundation of China (No. 21171132, https://doi.org/10.13039/501100001809).
-
Conflict of interest: The authors declare no conflicts of interest regarding this article.
References
1. Bruker. SAINT and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2000.Search in Google Scholar
2. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. OLEX2: a Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar
3. Sheldrick, G. M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar
4. Brandenburg, K. DIAMOND. Visual Crystal Structure Information System. Ver. 3.2; Crystal Impact: Bonn, Germany, 2012.Search in Google Scholar
5. Wang, L. H.; Tai, H. W.; Zhao, M. L.; Tai, X. S. Crystal Structure of Bis {μ2-(4-Acetyl-Phenoxy) Acetato-κ2 O: O′}-bis {μ2-(4-Acetyl-Phenoxy)acetato-κ3O, O′:O)-bis {(4-Acetyl-Phenoxy)acetato-κ2O, O′}-bis(phenanthrolin-κ2 N, N′)Didysprosium(III) Tetrahydrate, C84H78N4O28Dy2. Z. Kristallogr. N. Cryst. Struct. 2023, 238, 563–565; https://doi.org/10.1515/ncrs-2023-0086.Search in Google Scholar
6. Liu, Y.; Yan, X. H.; Wang, Y. F.; Tai, X. S. The Crystal Structure of catena-[diaqua-(4-Acetylphenoxyacetato-κ2 O,O)-bis(4-acetylphenoxyacetato-κ3O,O:O)-dihydrate-Lanthanum(III)]-4,4′-bipyridine (2/1), C35H35NO14La. Z. Kristallogr. N. Cryst. Struct. 2023, 238, 1061–1063; https://doi.org/10.1515/ncrs-2023-0301.Search in Google Scholar
7. Yi, S. J.; He, X.; Gu, S. Q.; Deng, Z. Y.; Li, J. H.; Yu, J. X.; Zhang, F. X.; Zhu, X. M. Microwave Solvothermal Syntheses, Crystal Structures, and In Vitro Antitumor Activity of Three Organotin 2,2′-biphenyl Dicarboxylate. Chinese J. Inorg. Chem. 2023, 39, 874–882.Search in Google Scholar
8. Tai, X. S.; Guo, H. M.; Guo, Q. Q. Synthesis, Crystal Structure and Antitumor Activity of a Novel Zn(II) Complex with 2-(nicotinoyloxy)acetic Acid Ligand. Chinese J. Struct. Chem. 2018, 37, 1052–1056.Search in Google Scholar
9. Li, Y. H.; Sun, P. P.; Deng, S. P.; Li, J. Q.; Li, C.; Wang, S. Y.; Liu, H. Y. Syntheses, Structures and Electrochemical Properties of Two Novel 2D Co-MOFs. Inorg. Chim. Acta 2024, 561, 121846; https://doi.org/10.1016/j.ica.2023.121846.Search in Google Scholar
10. Shah, H.; Shaukat, S.; Abdul, R.; Syed, T. H.; Mubbashir, H.; Iffat, N.; Aiyeshah, A. Synthesis, Spectroscopic Characterization, Antileishmanial, DNA Binding, Antioxidant, Cytotoxicity, Antifungal and Antibacterial Studies of Organotin(IV) Carboxylate Complexes. Arabian J. Chem. 2023, 16, 105306; https://doi.org/10.1016/j.arabjc.2023.105306.Search in Google Scholar
11. Abderrahim, T.; Mohamed, D.; Zakariae, A.; Mohamed, E. K.; Abdelkader, E. T.; Abderrahmane, Y.; Yousfi, E. B.; Touzani, R.; Siaj, M. New Catalysts Based on Carboxylate Sn(IV) Complexes Used in the Oxidation Reaction of 3,5-di-Tert-Butylcatechol to 3,5-di-tert-Butyl-o-Benzoquinone. React. Kinet. Mech. Catal. 2024, 137, 133–148; https://doi.org/10.1007/s11144-023-02525-6.Search in Google Scholar
12. Cao, S. H.; Tai, X. S.; Xin, C. L. Synthesis, Crystal Structure and Antitumor Activity of a Ca(II) Coordination Polymer Based on 4-acetylphenoxyacetate Ligands. Chinese J. Struct. Chem. 2021, 40, 324–328.Search in Google Scholar
13. Wang, L. H.; Tai, X. S. Synthesis, Structural Characterization, Hirschfeld Surface Analysis and Photocatalytic CO2 Reduction Activity of a New Dinuclear Gd(III) Complex with 6-Phenylpyridine-2-Carboxylic Acid and 1,10-phenanthroline Ligands. Molecules 2023, 28, 7595; https://doi.org/10.3390/molecules28227595.Search in Google Scholar PubMed PubMed Central
14. Liu, Y.; Tang, X.; Yan, X. H.; Wang, L. H.; Tai, X. S.; Azam, M.; Zhao, D. Q. The Synthesis, Structural Characterization, and DFT Calculation of a New Dinuclear Gd(III) Complex with 4-acetylphenoxyacetic Acid and 1,10-phenanthroline Ligands and its Roles in Catalytic Activity. Molecules 2024, 29, 3039; https://doi.org/10.3390/molecules29133039.Search in Google Scholar PubMed PubMed Central
15. Wang, L. H.; Tai, X. S.; Ren, X. J. The Crystal Structure of [(1,10-Phenanthroline-κ2 N,N)-bis(6-phenylpyridine-2-carboxylate-κ2N,O)Nickel(II)]monohydrate, C36H26N4O5Ni. Z. Kristallogr. N. Cryst. Struct. 2022, 237, 377–379; https://doi.org/10.1515/ncrs-2022-0046.Search in Google Scholar
© 2024 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- Crystal structure of the co-crystal 2,4,6-triamino-1,3,5-triazine-1,3-dioxide — acetic acid (1/2) C7H14N6O6
- Crystal structure of the dinuclear mercury(II) complex bis(μ2-bromido)-dibromido-bis{1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-ethyl-5-methyl-imidazol)-κ1 N} dimercury(II), C26H30N10Hg2Br4
- Crystal structure of poly[hexaqua-pentakis(μ4-2,2′-bipyridine-4,4′-dicarboxylato-κ4 O:O′:O″:O‴)-(μ2-2,2′-bipyridine-4,4′-dicarboxylato-κ2 O:O)tetraytterbium(III)] hydrate, C36H26N6O16Yb2
- Hydrothermal synthesis and crystal structure of catena-poly[(1,10-phenanthroline-κ 2 N,N′)-bis(μ 2-nitroisophthalato-κ 3 O,O′:O″)nickel(II)], C20H13NiN3O7
- Crystal structure of 72,73,75,76-tetrafluoro-25,44-dimethyl-31,33,36,38-tetraoxo-31,32,33,36,37,38-hexahydro-3(2,7)-benzo[lmn][3,8]phenanthrolina-1,5(4,1)-dipyridin-1-iuma-2,4(1,2),7(1,4)-tribenzenacyclooctaphane-11,51-diium hexafluoridophosphate, [C46H28F4N4O4][PF6]2, a dicationic cyclophane
- Crystal structure of (E)-2-(4-(1H-imidazol-1-yl)benzylidene)-7-fluoro-3,4-dihydronaphthalen-1(2H)-one, C20H15FN2O
- The salt crystal structure of etoricoxib hydrochloride, C18H16Cl2N2O2S
- The structure of t-butyl 7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate, C37H43FN2O5
- The crystal structure of (μ4-oxo)-tri(μ4-2,2′-bipyridine-6,6′-bis(olato)-κ5 O,O′:N:N′:O″)tetrazinc(II) – methylformamide (1/1), C33H25N7O8Zn4
- The co-crystal structure of 4-chlorobenzophenone–salicylhydrazide(1/1), C20H17ClN2O3
- Crystal structure of 9-fluoro-4-(6-methoxypyridin-2-yl)-5,6-dihydrobenzo[h]quinazolin-2-amine, C18H15FN4O
- The crystal structure of the co-crystal composed of benzhydrazide and 5-aminoisophthalic acid, C8H7NO4⋅C7H8N2O
- The cocrystal structure of praziquantel-hesperetin (1/1), C35H38N2O8
- Crystal structure of new barium manganese fluorides dihydrates, Ba10Mn2F25·2H2O
- The crystal structure of bis[μ2-(3-(3-(pyridin-2-yl)-1H-pyrazol-1-yl)propanoate-κ2O:N)-bis(2,2′-bipyridine-κ2 N, N′)dicopper(II)]dinitrate, C42H36Cu2N12O10
- Crystal structure of (3,6-di(2-pyridyl)-4-phenylaminopyridazine-κ2N,N′)-bis(2-(p-toluene)pyridinyl-κ2C,N)-iridium(III) hexafluorophosphate –dichloromethane (1/1), C45H37Cl2F6IrN7P
- The crystal structure of 2-(2′-carboxybenzyl)benzoic acid, C15H12O5
- The crystal structure of dichlorido-[(E)-N′,N″-bis((2E,3E)-3-(hydroxyimino)butan-2-ylidene)-2-((E)-3-(hydroxyimino)butan-2-ylidene)hydrazine-1-carbohydrazonhydrazide-κ 4 N 4]cobalt(II), C13H22N9O3Cl2Co
- Crystal structure of (−)-flavesine H, C15H22N2O2
- Crystal structure of 3-methoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C22H22O4
- Crystal structure of dicarbonyl(2-oxopyridin-1(2H)-olato-κ 2 O,O)iridium(I), C7H4IrNO4
- The crystal structure of 4-(3-(triphenylphosphonio)propyl)piperazin-1-ium dibromide trihydrate, C25H37Br2N2O3P
- The crystal structure of ethyl 5,6-dihydroxybenzofuran-3-carboxylate, C11H10O5
- Crystal structure of 14-(R)-(2′-cyano-phenoxy)-3,19-diacetyl andrographolide, C31H37NO7
- The twinned crystal structure of 10-(4-methyl benzoate)-2,8-diethyl-5,5-difluoro-1,3,7,9-tetramethyl-5H-di-pyrrolo[1,2-c:2′,1′-f] [1,3,2]diazaborinin-4-ium-5-uide, C25H29BF2N2O2
- The crystal structure of (9H-thioxanthen-9- ylidene)hydrazine monohydrate, C13H11N2SO0.5
- The crystal structure of pyridinium diaqua-{1,2-phenylenebis((carboxylatocarbonyl)amido-κ4 N,N′,O,O′)manganese(III), C15H14MnN3O8
- Crystal structure of the hydrogen storage active high entropy phase Tb0.82Sm0.18Ni0.83Co0.17Mg
- Crystal structure of diaqua-bis[5-methyl-1-(1H-pyrazol-3-yl)-1H-1,2,3-triazole-4-carboxylato-κ 2 N,O)]manganese(II), C14H16MnN10O6
- Crystal structures of diiodido-3-((pyridin-2-ylmethylene)amino)-2-(pyridin-3-yl)-2,3-dihydroquinazolin-4(1H)-one-cadmium(II)
- Synthesis and crystal structure of methyl 4-(2-ethoxy-2-oxoethoxy)-3,5-dimethoxybenzoate, C14H18O7
- Crystal structure of isoxazolo[4,5-b]pyridin-3-amine, C6H5N3O
- Crystal structure of 4-chloro-1-isobutyl-1H-imidazo, C14H14ClN3
- The crystal structure of 1,1,1,2,2,2-hexakis(2-methyl-2-phenylpropyl)distannane,C60H78Sn2
- The crystal structure of (2,7-dimethoxynaphthalene-1,8-diyl)bis((3-nitrophenyl)methanone), C26H18N2O8
- Crystal structure of diaqua-tetra((E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol-κ 1 N)zinc(II) dinitrate dihydrate, C60H76Cl8N14O14Zn
- The crystal structure of diphenyl bis(2-((diphenoxyphosphoryl)amino)ethyl)phosphoramidate monohydrate C40H42N3O10P3
- Crystal structure of 4,4′-bis(dibromomethyl)-1,1′-biphenyl, C14H10Br4
- Crystal structure of CaPtZn
- Crystal structure of 3-chloro-5-(trifluoromethyl)pyridine-2-carboxylic acid, C7H3ClF3NO2
- The crystal structure of (3′-(2-bromophenyl)-2-phenyl-[2,2′-bioxiran]-3-yl)(phenyl)methanone, C92H68O12Br4
- Crystal structure of ethyl 4-(4-benzylpiperazin-1-yl)benzoate, C20H24N2O2
- The crystal structure of bis(selenocyanato-κ1 N)-bis(methanol)-bis((1E,2E)-1,2-bis (1-(pyridin-4-yl)ethylidene)-hydrazine)iron(II) methanol solvate, C34H44FeN10O4Se2
- Crystal structure of (E)-1-(5-bromo-2-hydroxyphenyl)-3-(5-(4-methoxyphenoxy)-3-methyl-1-phenyl-1H-pyrazol-4-yl)prop-2-en-1-one, C26H21BrN2O4
- The crystal structure of methyl 4-(4-(methylsulfonyl)phenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C19H21NO5S
- Crystal structure of 1′,3′-dihydro-2,2′-spirobi[indene]-1,3-dione, C17H12O2
- Crystal structure of (E)-2,2′,3,3′-tetrahydro-[1,1′-biindenylidene]-4,4′-diol, C18H16O2
- Crystal structure of di-glycylglycinium squarate dihydrate, C12H22N4O12, at 105 K
- Crystal structure of {[(4-fluorophenyl)methyl]triphenylphosphonium}dibromocopper(I), [C25H21FP]+[CuBr2]−
- Crystal structure of poly[diaqua-bis(μ2-5-((pyridin-4-yl-methyl)amino)benzene-1,3-dicarboxylato-κ 2 N:O)cadmium(II)], C28H26CdN4O10
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- Crystal structure of the co-crystal 2,4,6-triamino-1,3,5-triazine-1,3-dioxide — acetic acid (1/2) C7H14N6O6
- Crystal structure of the dinuclear mercury(II) complex bis(μ2-bromido)-dibromido-bis{1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-ethyl-5-methyl-imidazol)-κ1 N} dimercury(II), C26H30N10Hg2Br4
- Crystal structure of poly[hexaqua-pentakis(μ4-2,2′-bipyridine-4,4′-dicarboxylato-κ4 O:O′:O″:O‴)-(μ2-2,2′-bipyridine-4,4′-dicarboxylato-κ2 O:O)tetraytterbium(III)] hydrate, C36H26N6O16Yb2
- Hydrothermal synthesis and crystal structure of catena-poly[(1,10-phenanthroline-κ 2 N,N′)-bis(μ 2-nitroisophthalato-κ 3 O,O′:O″)nickel(II)], C20H13NiN3O7
- Crystal structure of 72,73,75,76-tetrafluoro-25,44-dimethyl-31,33,36,38-tetraoxo-31,32,33,36,37,38-hexahydro-3(2,7)-benzo[lmn][3,8]phenanthrolina-1,5(4,1)-dipyridin-1-iuma-2,4(1,2),7(1,4)-tribenzenacyclooctaphane-11,51-diium hexafluoridophosphate, [C46H28F4N4O4][PF6]2, a dicationic cyclophane
- Crystal structure of (E)-2-(4-(1H-imidazol-1-yl)benzylidene)-7-fluoro-3,4-dihydronaphthalen-1(2H)-one, C20H15FN2O
- The salt crystal structure of etoricoxib hydrochloride, C18H16Cl2N2O2S
- The structure of t-butyl 7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate, C37H43FN2O5
- The crystal structure of (μ4-oxo)-tri(μ4-2,2′-bipyridine-6,6′-bis(olato)-κ5 O,O′:N:N′:O″)tetrazinc(II) – methylformamide (1/1), C33H25N7O8Zn4
- The co-crystal structure of 4-chlorobenzophenone–salicylhydrazide(1/1), C20H17ClN2O3
- Crystal structure of 9-fluoro-4-(6-methoxypyridin-2-yl)-5,6-dihydrobenzo[h]quinazolin-2-amine, C18H15FN4O
- The crystal structure of the co-crystal composed of benzhydrazide and 5-aminoisophthalic acid, C8H7NO4⋅C7H8N2O
- The cocrystal structure of praziquantel-hesperetin (1/1), C35H38N2O8
- Crystal structure of new barium manganese fluorides dihydrates, Ba10Mn2F25·2H2O
- The crystal structure of bis[μ2-(3-(3-(pyridin-2-yl)-1H-pyrazol-1-yl)propanoate-κ2O:N)-bis(2,2′-bipyridine-κ2 N, N′)dicopper(II)]dinitrate, C42H36Cu2N12O10
- Crystal structure of (3,6-di(2-pyridyl)-4-phenylaminopyridazine-κ2N,N′)-bis(2-(p-toluene)pyridinyl-κ2C,N)-iridium(III) hexafluorophosphate –dichloromethane (1/1), C45H37Cl2F6IrN7P
- The crystal structure of 2-(2′-carboxybenzyl)benzoic acid, C15H12O5
- The crystal structure of dichlorido-[(E)-N′,N″-bis((2E,3E)-3-(hydroxyimino)butan-2-ylidene)-2-((E)-3-(hydroxyimino)butan-2-ylidene)hydrazine-1-carbohydrazonhydrazide-κ 4 N 4]cobalt(II), C13H22N9O3Cl2Co
- Crystal structure of (−)-flavesine H, C15H22N2O2
- Crystal structure of 3-methoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C22H22O4
- Crystal structure of dicarbonyl(2-oxopyridin-1(2H)-olato-κ 2 O,O)iridium(I), C7H4IrNO4
- The crystal structure of 4-(3-(triphenylphosphonio)propyl)piperazin-1-ium dibromide trihydrate, C25H37Br2N2O3P
- The crystal structure of ethyl 5,6-dihydroxybenzofuran-3-carboxylate, C11H10O5
- Crystal structure of 14-(R)-(2′-cyano-phenoxy)-3,19-diacetyl andrographolide, C31H37NO7
- The twinned crystal structure of 10-(4-methyl benzoate)-2,8-diethyl-5,5-difluoro-1,3,7,9-tetramethyl-5H-di-pyrrolo[1,2-c:2′,1′-f] [1,3,2]diazaborinin-4-ium-5-uide, C25H29BF2N2O2
- The crystal structure of (9H-thioxanthen-9- ylidene)hydrazine monohydrate, C13H11N2SO0.5
- The crystal structure of pyridinium diaqua-{1,2-phenylenebis((carboxylatocarbonyl)amido-κ4 N,N′,O,O′)manganese(III), C15H14MnN3O8
- Crystal structure of the hydrogen storage active high entropy phase Tb0.82Sm0.18Ni0.83Co0.17Mg
- Crystal structure of diaqua-bis[5-methyl-1-(1H-pyrazol-3-yl)-1H-1,2,3-triazole-4-carboxylato-κ 2 N,O)]manganese(II), C14H16MnN10O6
- Crystal structures of diiodido-3-((pyridin-2-ylmethylene)amino)-2-(pyridin-3-yl)-2,3-dihydroquinazolin-4(1H)-one-cadmium(II)
- Synthesis and crystal structure of methyl 4-(2-ethoxy-2-oxoethoxy)-3,5-dimethoxybenzoate, C14H18O7
- Crystal structure of isoxazolo[4,5-b]pyridin-3-amine, C6H5N3O
- Crystal structure of 4-chloro-1-isobutyl-1H-imidazo, C14H14ClN3
- The crystal structure of 1,1,1,2,2,2-hexakis(2-methyl-2-phenylpropyl)distannane,C60H78Sn2
- The crystal structure of (2,7-dimethoxynaphthalene-1,8-diyl)bis((3-nitrophenyl)methanone), C26H18N2O8
- Crystal structure of diaqua-tetra((E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol-κ 1 N)zinc(II) dinitrate dihydrate, C60H76Cl8N14O14Zn
- The crystal structure of diphenyl bis(2-((diphenoxyphosphoryl)amino)ethyl)phosphoramidate monohydrate C40H42N3O10P3
- Crystal structure of 4,4′-bis(dibromomethyl)-1,1′-biphenyl, C14H10Br4
- Crystal structure of CaPtZn
- Crystal structure of 3-chloro-5-(trifluoromethyl)pyridine-2-carboxylic acid, C7H3ClF3NO2
- The crystal structure of (3′-(2-bromophenyl)-2-phenyl-[2,2′-bioxiran]-3-yl)(phenyl)methanone, C92H68O12Br4
- Crystal structure of ethyl 4-(4-benzylpiperazin-1-yl)benzoate, C20H24N2O2
- The crystal structure of bis(selenocyanato-κ1 N)-bis(methanol)-bis((1E,2E)-1,2-bis (1-(pyridin-4-yl)ethylidene)-hydrazine)iron(II) methanol solvate, C34H44FeN10O4Se2
- Crystal structure of (E)-1-(5-bromo-2-hydroxyphenyl)-3-(5-(4-methoxyphenoxy)-3-methyl-1-phenyl-1H-pyrazol-4-yl)prop-2-en-1-one, C26H21BrN2O4
- The crystal structure of methyl 4-(4-(methylsulfonyl)phenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C19H21NO5S
- Crystal structure of 1′,3′-dihydro-2,2′-spirobi[indene]-1,3-dione, C17H12O2
- Crystal structure of (E)-2,2′,3,3′-tetrahydro-[1,1′-biindenylidene]-4,4′-diol, C18H16O2
- Crystal structure of di-glycylglycinium squarate dihydrate, C12H22N4O12, at 105 K
- Crystal structure of {[(4-fluorophenyl)methyl]triphenylphosphonium}dibromocopper(I), [C25H21FP]+[CuBr2]−
- Crystal structure of poly[diaqua-bis(μ2-5-((pyridin-4-yl-methyl)amino)benzene-1,3-dicarboxylato-κ 2 N:O)cadmium(II)], C28H26CdN4O10